Baird Financial Group’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
BCI
Baird Financial Group's PPH Position: Q3 2019 in Review
Baird Financial Group sold out of VanEck Pharmaceutical ETF (PPH) in Q3 2019, closing a stake of 3,935 shares — an estimated $231K sold.
Baird Financial Group first reported a position in PPH in Q2 2015 and held it in 17 quarters. The position peaked at $1.3M in Q2 2015. 43 funds tracked by Wall St. Rank hold PPH as of Q3 2019.
- Baird Financial Group reported no remaining VanEck Pharmaceutical ETF position as of Q3 2019 after selling out during the quarter.
- Baird Financial Group sold 3,935 VanEck Pharmaceutical ETF shares in Q3 2019, an estimated $231K.
- Baird Financial Group first reported a position in VanEck Pharmaceutical ETF in Q2 2015 and held it in 17 quarters.
- Baird Financial Group's VanEck Pharmaceutical ETF position peaked at $1.3M in Q2 2015.
- 43 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2019.
Based on Baird Financial Group's 13F filing for Q3 2019, filed 14 Nov 2019.